Although telmisartan reduced the production of collagen I and collagen III induced by PRR overexpression in CFs, it had no significant effect on the production of TGF-β or the phosphorylation of ERK1/2-MAPK. Here, ATP6AP2 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.